The $16M USD round was led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai; OneCell to continue transforming the future of precision oncology with U.S. market entry CUPERTINO, Calif. and MUMBAI, India, Nov. 21, 2024 /PRNewswire/ -- OneCell Diagnostics, a...
OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology
Seaking AlphaSeeking Alpha / Seaking Alpha 2 hours ago 1 Views
Comments